Pfizer (PFE) said Monday Patrizia Cavazzoni will be rejoining the company as chief medical officer.
Cavazzoni was most recently the director of the Center for Drug Evaluation and Research at the US Food and Drug Administration, Pfizer said.
Cavazzoni will succeed Aida Habtezion who will be leaving Pfizer to pursue other opportunities.
Price: 26.44, Change: +0.14, Percent Change: +0.53
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.